Michael Castellano - BlackRock Science Independent Trustee
BST Etf | USD 34.43 0.33 0.97% |
Mr. Michael J. Castellano is Independent Blackrock Science And Technology Trust . The Board benefits from Mr. Castellanos career in accounting which spans over forty years
Age | 75 |
Tenure | 11 years |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Similar Fund Executives
Showing other executives | One Year Return | ||
William Reardon | Tekla Healthcare Investors | 74 | |
Alan Rappaport | Pimco Corporate Income | 68 | |
Kyle CFA | BlackRock Health Sciences | N/A | |
Mark Fetting | Eaton Vance Enhanced | 67 | |
Susan Sutherland | Eaton Vance Enhanced | 64 | |
Helen Peters | Eaton Vance Enhanced | 73 | |
Lindsay Sinclair | BlackRock Utility Infrastructur | N/A | |
Charles Park | BlackRock Utility Infrastructur | 58 | |
Lisa Phelan | Cohen Steers Total | 51 | |
Janey Ahn | BlackRock Health Sciences | 46 | |
Larry Papasan | Reaves Utility If | 79 | |
Christopher Accettella | BlackRock Health Sciences | N/A | |
Erin Xie | BlackRock Health Sciences | 57 | |
Stacie Anctil | Pimco Corporate Income | 51 | |
Frank Fabozzi | BlackRock Health Sciences | 73 | |
Xiang Liu | BlackRock Health Sciences | N/A | |
Rakesh Jain | Tekla Healthcare Investors | 69 | |
Cynthia Frost | Eaton Vance Enhanced | 60 | |
William Ogden | Pimco Corporate Income | 75 | |
Lisa Phelan | Cohen Steers Qualityome | 52 | |
Christopher MBA | Tekla Healthcare Investors | N/A |
BlackRock Science Tech Money Managers
Henry Gabbay, Independent Trustee | ||
Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Cynthia Egan, Independent Trustee | ||
Jay Fife, Treasurer | ||
R Hubbard, Independent Trustee | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Neal Andrews, Chief Financial Officer | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 33.68 M | ||||
Shares Owned By Insiders | 0.01 % | ||||
Shares Owned By Institutions | 18.53 % | ||||
Number Of Shares Shorted | 14.74 K | ||||
Price To Earning | 5.78 X | ||||
Short Ratio | 0.09 X | ||||
Earnings Per Share | 5.41 X | ||||
Number Of Employees | 17 | ||||
Market Capitalization | 1 B | ||||
Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.